CUE-301

N/A

Report date: 2024/11/12 15:24:06

Base Information

Drug NameCUE-301

Drug Alias NameCUE-301

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProgrammed death-ligand 1 modulatorsTNF-related apoptosis-inducing ligand receptors modulators

TargetsProgrammed death-ligand 1TNF-related apoptosis-inducing ligand receptors

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCue Biopharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 1

Inactive IndicationsN/A

ATC CodeN/A